Evidence map›Paper›PMID 18722135›Full record

ReviewCytokine2008

Chemotaxis, chemokine receptors and human disease.

Tian Jin, Xuehua Xu, Dale Hereld

Open access · greenAbstract readReview
In one paragraph

Review in Cytokine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 3 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 3 syntheses or guidelines pooled it, 281 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Modeling Immunity In Vitro: Slices, Chips, and Engineered Tissues.Annual review of biomedical engineering · 2021
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. GαInternational journal of molecular sciences · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Spontaneous signal generation by an excitable system for cell migration.Frontiers in cell and developmental biology · 2024
    Review

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Tian JinChemotaxis Signal Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, NIH, Twinbrook II Facility, 12441 Parklawn Drive, Rockville, MD 20852, USA. tjin@niaid.nih.gov
Xuehua Xu
Dale Hereld
Georgetown University Medical Center · USNational Institute of Allergy and Infectious Diseases · USNational Institute on Alcohol Abuse and Alcoholism · US

Funding

The mechanisms underlying the GPCR-mediated chemotaxis in D. discoideumZIAAI000916 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI JIN, TIAN · 2009 to 2025
$12.3M
G-protein Coupled Receptor Mediated Directional SensingZ01AI000916 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI JIN, TIAN · 2002 to 2008
$1.2M
Using FRET to Probe the Spatial Distributions of CD4, CXCR4 and CCR5 on MembraneZ01AI000928 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI JIN, TIAN · 2003 to 2008
$906k
Intramural NIH HHS Z01 AI000916Intramural NIH HHS Z01 AI000928
6 · The paper itself

Abstract

Cell migration is involved in diverse physiological processes including embryogenesis, immunity, and diseases such as cancer and chronic inflammatory disease. The movement of many cell types is directed by extracellular gradients of diffusible chemicals. This phenomenon, referred to as "chemotaxis", was first described in 1888 by Leber who observed the movement of leukocytes toward sites of inflammation. We now know that a large family of small proteins, chemokines, serves as the extracellular signals and a family of G-protein-coupled receptors (GPCRs), chemokine receptors, detects gradients of chemokines and guides cell movement in vivo. Currently, we still know little about the molecular machineries that control chemokine gradient sensing and migration of immune cells. Fortunately, the molecular mechanisms that control these fundamental aspects of chemotaxis appear to be evolutionarily conserved, and studies in lower eukaryotic model systems have allowed us to form concepts, uncover molecular components, develop new techniques, and test models of chemotaxis. These studies have helped our current understanding of this complicated cell behavior. In this review, we wish to mention landmark discoveries in the chemotaxis research field that shaped our current understanding of this fundamental cell behavior and lay out key questions that remain to be addressed in the future.

Indexed as

AnimalsBridged Bicyclo Compounds, HeterocyclicCell MovementChemokinesChemotaxisDictyosteliumHIV Envelope Protein gp120HIV InfectionsHumansPulmonary Disease, Chronic ObstructiveReceptors, CCR5Receptors, ChemokineReceptors, HIVThiazolidinesBridged Bicyclo Compounds, HeterocyclicChemokinesHIV Envelope Protein gp120latrunculin AReceptors, CCR5Receptors, ChemokineReceptors, HIVThiazolidines

Identifiers

PMID18722135
PMCPMC2613022
OpenAlexW2048340704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.